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Nonparametric Pathway-Based Regression
Models for Analysis of Genomic Data
Zhi Wei and Hongzhe Li

Abstract

High-throughout genomic data provide an opportunity for identifying pathways
and genes that are related to various clinical phenotypes. Besides these genomic
data, another valuable source of data is the biological knowledge about genes
and pathways that might be related to the phenotypes of many complex diseases.
Databases of such knowledge are often called the metadata. In microarray data
analysis, such metadata are currently explored in post hoc ways by gene set enrichment analysis but have hardly been utilized in the modeling step. We propose
to develop and evaluate a pathway-based gradient descent boosting procedure for
nonparametric pathways-based regression(NPR) analysis to efficiently integrate
genomic data and metadata. Such NPR models consider multiple pathways simultaneously and allow complex interactions among genes within the pathways
and can be applied to identify pathways and genes within pathways that are related to variations of the phenotypes. These methods also provide an alternative
to mediating the problem of a large number of potential interactions by limiting
analysis to biologically plausible interactions between genes in related pathways.
Our simulation studies indicate that the proposed boosting procedure can indeed
identify relevent pathways and genes within pathways. Application to a gene expression data set on breast cancer distant matastasis identified that Wnt, apoptosis
and cell cycle regulated pathways are more likely related to the risk of distant
metastasis among lymph-node-negative breast cancer patients. We also observed
that by incorporating the pathway information, we achieved better prediction for
cancer recurrence.
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SUMMARY. High-throughout genomic data provide an opportunity for identifying pathways
and genes that are related to various clinical phenotypes. Besides these genomic data, another
valuable source of data is the biological knowledge about genes and pathways that might be
related to the phenotypes of many complex diseases. Databases of such knowledge are often
called the metadata. In microarray data anlysis, such metadata are currently explored in post
hoc ways by gene set enrichment analysis but have hardly been utilized in the modeling step.
We propose to develop and evaluate a pathway-based gradient descent boosting procedure for
nonparametric pathways-based regression (NPR) analysis to efficiently integrate genomic data
and metadata. Such NPR models consider multiple pathways simultaneously and allow complex
interactions among genes within the pathways and can be applied to identify pathways and genes
within pathways that are related to variations of the phenotypes. These methods also provide
an alternative to mediating the problem of a large number of potential interactions by limiting
analysis to biologically plausible interactions between genes in related pathways. Our simulation
studies indicate that the proposed boosting procedure can indeed identify relevant pathways
and genes within pathways. Application to a gene expression data set on breast cancer distant
metastasis identified that Wnt, apoptosis and cell cycle regulated pathways are more likely related to the risk of distant metastasis among lymph-node-negative breast cancer patients. We
also observed that by incorporating the pathway information, we achieved better prediction for
cancer recurrence.

KEY WORDS: Microarray; SNPs; Gradient descent boosting; Tree; Gene set enrichment
analysis; Additive models.
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1

Introduction

New high-throughput technologies are generating many types of high-dimensional genomic and
proteomic data in biomedical research. Important examples include microarray gene expression
data measuring mRNA transcripts of about 25,000 genes in cells and single nucleotide polymorphisms (SNPs) array data on genotypes of over 500K SNPs. One important application of
such data is to identify genes, their interactions, and pathways that might be related to various
clinically relevant phenotypes, such as risk of developing cancers or outcomes from cancer treatments. One great challenge in studying the relationship between genomic data and phenotypes
is to deal with high-dimensionality of the data and to model complex interactions between genes.
Many new statistical and computational methods have been or are still being developed to solve
this problem of ”curse of dimensionality.” Important recent developments include support vector
machine (SVM) (Vapnik, 1998) and random forest methods (Breiman, 2001), which have gained
much popularity in building predictive models and in identifying genes that are related to clinical
phenotypes.
One limitation of all these popular approaches is that the methods are developed purely
from computational or algorithmic points without utilizing any prior biological knowledge or
information. For many complex diseases, especially for cancers, much biological knowledge or
pathway information is available from many years of intensive biomedical research. The large
body of information is now available, primarily through databases on different aspects of the
biological systems. Such databases are often called metadata, which means data about data.
Examples of such metadata include the gene ontology (GO) database (Gene Ontology Consortium, 2001), the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (Kanehisa and
Goto, 2000), and other pathways databases available on the internet (e.g., www.superarray.com,
www.biocarta.com). Currently, information derived from metadata such as known biological
knowledge has been used primarily to select promising candidates for genetic risk characteriza2
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tion and for studying gene-gene and gene-environment interactions in genetic association studies.
For microarray gene expression data, the most commonly used approach for pathway analysis is
to identify pathways that are over-represented by differentially expressed genes. Some popular
tools include GENMAPP, CHIPINFO, GOMINER and ONTO-TOOLS. Such gene set enrichment analyses (GSEA) are of course very informative and are potentially useful (Tian et al.,
2005) for identifying pathways that might be related to the disease phenotypes. However, such
information has not been utilized in the modeling stage for identifying genes, their interactions,
and pathways that are related to the phenotypes. In addition, such GSEA analysis considers
pathways separately. Since many complex phenotypes are believed to be associated with activity
levels of multiple pathways, new statistical methods are required to consider multiple pathways
simultaneously and to allow complex gene-gene interactions within pathways.
We propose in this paper to develop and evaluate a novel gradient descent boosting procedure for nonparametric pathways-based regression (NPR) analysis in order to efficiently integrate
genetic or genomic data and metadata. Our approach utilizes both statistical methods and biological knowledge in reducing the dimensionality of the problem and in building pathways-based
regression models. Compared to GSEA analysis, our NPR model considers multiple potential
pathways simultaneously. In such an NPR modeling framework, known biological pathways are
treated as first level regression units, and the genes within the pathways are treated as the second
level regression units, where the genomic data, such as the expression levels of genes or SNPs data
in a given pathway, are used to characterize the activity of the pathways and the activity levels
across many pathways are related to the phenotypes by a regression model. This provides a nice
biological interpretation of the resulting regression models. In addition, the NPR also provides
an alternative of mediating the problem of a large number of potential interactions by limiting
analysis to biologically plausible interactions between genes in related pathways. In general, risk
interactions are more plausible between genes involved in a physical interaction, found in the
3
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same pathways, or involved in the same regulatory network (Carlson et al., 2004).
Boosting was introduced in the machine learning literature by Freund (1995) and Freund and
Schapire (1996) and has demonstrated great empirical success on a wide variety of specially highdimensional prediction problems, including analysis of microarray gene expression data (Dettling
and Buhlmann, 2003; Horton et al., 2005; Li and Luan, 2005). From the perspective of numerical
optimization on function space, Friedman (2001) proposed a gradient descent boosting (GDB)
procedure and demonstrated that such a procedure can be regarded as a stage-wise fitting of the
additive models. We propose an extension of Friedman’s GDB procedure to perform GDB by
pathways for fitting the proposed NPR models using regression trees as weak learners. We also
provide scores for assessing the relative importance of the genes and pathways.
The rest of the paper is organized as follows: we first introduce the NPR models. We then
present a general pathway-based GDB procedure for identifying such NPR models for both
the logistic regression model and the Cox proportional hazards model. We present simulation
studies and analysis of a breast cancer distance metastasis data set to demonstrate and evaluate
the proposed methods. Finally, we give brief discussion of the methods and results.

2

Nonparametric Pathway-Based Regression Models

Suppose that we have K pathways whose activities may be related to the phenotype of interest.
Assume that there are pk genes involved in the kth pathway. We allow that some genes belong
to multiple pathways and let p be the total number of genes involved in the K pathways and
P
therefore p ≤ K
k=1 pk . Suppose that we have n independent individuals and we let yi denote
the phenotype (can be continuous, categorical, or censored survival data) for the ith individual.
For binary phenotype, let yi = 1 if the ith individual has the phenotype and -1 otherwise. For
censored survival outcome, let yi = (ti , δi ), where ti is time to event or censoring and δi is an
(k)

event indicator. Let xij be the genomic measurement of the jth gene in the kth pathway for
4
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(k)

the ith patient, xi

(k)

(k)

= {xi1 , · · · , xipk } be the vector of the genomic measures of the genes in
(1)

(K)

the kth pathway for the ith patient, and let xi = (xi , · · · , xi ) be the vector of the genomic
measurements of all the p genes. Here the genomic measurements can be SNP data or gene
expression data. Our goal is to relate the phenotype data Y to X = {X (1) , · · · , X (K) } in order
to identify the pathways that are related to the phenotype and to identify genes and their
interactions that determine the pathway activities.
Here we assume that the phenotype is related to the total activity level across multiple
pathways through an additive model,
F (X) =

K
X

Fk (X (k) ),

(1)

k=1

where Fk (X

(k)

) can be interpreted as the activity level associated with the kth pathway as

determined by the genomic measurements of the pk genes in this pathway. We assume that
conditioning on the genes of the pathways, the pathway activities across the K pathways are
additive. For example, for a binary phenotype such as disease status or normal versus cancerous
tissues, we can assume a generalized linear model such as a logistic model for Y ,
P r(Y = 1) =

exp(2(F (X) + γZ))
,
1 + exp(2(F (X) + γZ))

(2)

where Y = 1 for diseased individual and Y = −1 for normal individual, Z is the vector of other
patient-specific covariates which is modeled parametrically with coefficients γ. For the censored
survival phenotype, we can assume that the hazard function at time t given the observed genomic
data X is modeled as
λ(t|X, Z) = λ0 (t) exp(F (X) + γZ),

(3)

where λ0 (t) is the baseline hazard function and Z is a covariate vector and γ is the corresponding
risk ratio parameter.
The main motivation of these models is that we aim to model complex interactions between
genes within pathways nonparametrically, rather than assume particular parametric forms for
5
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functions Fk (X (k) . We use the term ”nonparametric pathway-based regression” to particularly
emphasize this point, i.e., the genetic and pathways effects are modeled nonparametrically. It
is obvious that without any constraints on the functions Fk (X (k) ), model (2) or (3) is not identifiable. In the next section, we propose a general pathway-based gradient descent boosting
procedure to identify such NPR models with the particular form of (2) or (3).

3

A Pathway-Based GDB procedure for the NPR models

We propose to extend the GDB procedure of Friedman (2001) to obtain an additive model with
the form of model (1) using regression trees (Breiman et al., 1984) as base learners. Regression
trees provide a flexible way of modeling dependency between responses and the predictors and
have been widely used in the context of boosting methods (Friedman et al., 2001; Friedman,
2001). We also propose several statistics for assessing the importance of the genes and pathways
that are related to the phenotype of interest.

3.1

A pathway-based GDB procedure for the NPR models

The key idea of our proposed extension of the boosting procedure of Friedman (2001) is that
instead of performing gradient boosting over all the p genes, we perform gradient descent boosting
over genes in each of the K pathways separately. We first consider the case when no other
covariates are included in model (2) or (3). Let L(yi , F (xi )) be a loss function for the ith
observation, which depends on the type of the phenotype. For binary phenotype and model (2),
the loss function can be defined as
L(y, F (x)) =

n
X
i=1

L(yi , F (xi )) =

n
X

log(1 + exp(−2yi F (xi ))), yi ∈ {−1, 1}.

(4)

i=1

This is also the loss function used by Friedman et al. (2001) for LogitBoost and by Friedman
(2001) for his GDB procedure. For survival phenotype, the loss function can be defined as
6
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negative of the partial likelihood based on model (3),
L(y, δ, F (x)) =

n
X

L(yi , δi , F (xi )) = −

n
X

i=1

n
X
δi {F (xi ) − log(
1{yj ≥yi } exp(F (xj )))}.

i=1

(5)

j=1

This loss function is used in Li and Luan (2005) and Gui and Li (2005).
Extending the GDB procedure of Friedman (2001), our proposed pathway-based GDB procedure for the NPR models involves the following steps:
A Pathways-based GDB Procedure for the NPR models
(0)

1. Initialization, F (0) (X) = 0, Fk (X (k) ) = 0, k = 1, · · · , K.
Repeat, for m = 1 to M (boosting steps) do:
2. Calculating the gradients w.r.t. each function Fk (X (k) ) over observed samples,


∂L(yi ,F (xi ))
, i = 1, · · · , n, k = 1, · · · , K.
ỹi = −
(k)
∂Fk (xi )

F (X)=F (m−1) (X)
(k)

3. Fitting trees to the gradient vector using x(k) , let hk (xi ; a) be the base learner procedure,
P
(k)
2
(a(k) , β (k) ) = argmina,β N
i=1 [ỹi − βhk (xi ; a)] , k = 1, · · · , K,
P
(k)
(k)
hk (xi ; a(k) )]2 .
Let k ∗ = argmink N
i=1 [ỹi − β
4. Line search over ρ for the pathway k ∗ selected in step 3,
P
∗
(k∗ )
ρm = argmin ni=1 L(yi , F (m−1) (xi ) + ρhk∗ (xi ; a(k ) )).
5. Updating the function with ν being the learning rate,
(m)

∗

(m−1)

Fk∗ (X (k ) ) = Fk∗

(k∗ )

+ νρm hk∗ (xi
(m)

∗

; a(k ) )

,

∗

F (m) (X) = F (m−1) (X) + Fk∗ (X (k ) ).
end For
end Algorithm
where M is the number of iterations, which serves as a shrinkage parameter and can be determined
(m)

by cross-validation, F (m) (X) denotes the function F (X) and Fk (x(k) ) denotes the function
Fk (x(k) ) at the mth boosting step. Note that when K = 1, this algorithm reduces to the boosting
7
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algorithm of Friedman (2001). In this algorithm, the gradients in step 2 of the generalized
boosting algorithm are


∂L(yi , F (xi ))
= 2yi /(1 + exp(2yi Fm−1 (xi ))))
ỹik = −
∂Fk (x(k) ) F (X)=Fm−1 (X)

(6)

for the logistic model (2)and
ỹik = δi −

n
X

exp(Fm (xi ))
,
r=1 1{tr ≥tj } exp(Fm (xr ))

δj 1{ti ≥tj } Pn

j=1

for the Cox model (3). Note that these gradients are the same for each different pathway k.
The key difference from the GDB algorithm of Friedman (2001) is found in step 3 and 4, where
the calculation is done on a pathway by pathway basis. Step 3 aims to identify the pathway
that gives the best fit of the negative gradients using the base learner. This effectively utilizes
the known pathway information and reduces the dimensionality from considering all the genes
to only considering those genes in a given pathway. In steps 4 and 5, the functions are updated
by adding the tree corresponding to the k ∗ th pathway selected in Step 3. For many models, Step
4 simply reduces to a regression problem with a case weight.
In order to model interactions between genes in a given pathway, we propose to use a Jterminal node regression tree (Breiman et al., 1984) as the base learning procedure in Step 3 of
the algorithm for each pathway. For pathway k, each regression tree itself has the additive form
hk (X

(k)

(k)
(k)
; {bj , Rj }Jj=1 )

=

J
X

(k)

(k)

bj I(X (k) ∈ Rj ),

j=1
(k)

where {Rj }, j = 1, · · · , J are disjoint regions that cover the space of all joint values of the
(k)

(k)

variables X (k) , and a(k) = {bj , Rj }Jj=1 in the general boosting algorithm for the NPR models
(Step 4). The boosting procedure with regression trees as base procedures inherits the favorable
characteristics of trees such as robustness, and flexibility in modeling interactions (Breiman et
al., 1984). In addition, trees tend to be quite robust against the addition of irrelevant input
variables and therefore serve as internal feature selection (Friedman, 2001; Breiman et al., 1984).
J controls the size of the tree, which is often chosen to be small.
8
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Finally, if covariates Z are included in the NPR models (3) or (2), we can iterate between
updating the parametric parameters γ by minimizing the loss function with F (X) fixed and
updating the nonparametric term F (X) using the proposed boosting procedure.

3.2

Identification of important pathways and genes

We propose to apply cross-validation on the error rates for the logistic model (2) or the crossvalidated partial likelihood to determine the number of boosting steps M . After M is determined
and the function Fk (X (k) ) is estimated, we can address the issue of identifying relative importance
of genes to the activity level of each pathway and identifying important pathways that are related
to the phenotypes in the proposed NPR modeling framework. Although single trees are highly
interpretable (Breiman et al., 1984), the final function F (X) identified by the pathways-based
TGD procedure is a linear combination of trees and must therefore be interpreted in a different
way. For a single tree T , Breiman et al. (1984) proposed to use
Il2 (T )

=

J−1
X

î2t I(v(t) = l)

(7)

t=1

as a measurement of relevance for each predictor variable Xl for a tree with J nodes, where
the sum is over the J − 1 internal nodes, I(.) is an indicator function and v(t) is the splitting
variable associated with the tth node. This score is basically the summation of the empirical
improvement î2t in squared error risk as a result of a split at node t over the J − 1 internal nodes
of the tree. For models of additive tree expansions obtained from M boosting steps, Friedman
(2001) suggested an importance score for the lth variable as
Il2 =

M
1 X 2
I (Tm ),
M m=1 l

(8)

which is simply an average of the importance scores over the M trees obtained during the M
boosting steps.
9
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The importance scores defined by equations (7) and (8) can equally be applied to the additive trees obtained from the proposed pathways-based boosting procedure for the NPR models.
However, for the final additive trees from the NPR model, we can in fact address more detailed
questions about the role that genes and pathways play in determining the phenotypes. First, for
each pathway k, we can assess the relevant influence of each gene j in this pathway by calculating
the importance scores using the trees constructed based on the kth pathway, i.e.,
Mk
1 X
2
ˆ
I 2 (Tmk ),
Ilk =
Mk m=1 l

where Mk is the number of times that the k pathway was selected in Step 3 of the proposed
pathway-based boosting algorithm, and Tmk is the mth tree built based on the kth pathway.
Second, the average of importance scores for genes selected within a pathway, which we call
the pathway importance score, can be used as a measure of importance of this pathway to the
phenotype. As in Friedman (2001), the most influential variable or pathway is given a score of
1, and the estimated importance scores of others are scaled accordingly.

4

Simulation Studies

In order to evaluate the performance of NPR’s ability to identify important pathways and
genes, we designed the following simulation studies, mimicking different possible biological scenarios. We assume that there are 50 candidate SNPs, denoted by X1 , . . . , X50 , where SNPs
X(k−1)∗10+1 , . . . , X(k−1)∗10+10 belong to the kth pathway, for k = 1, · · · , 5. We generate Xi s independently from Bernoulli distribution with probability of 0.25 of being 1. We generate disease
status variable Y based on the following logistic regression model,
P r(Y = 1|X) =

exp(2F (X))
1 + exp(2F (X))

(9)

10
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where Y = 1 for disease and Y = −1 for disease-free. We consider four different models with the
following four predictive functions,
F1 (X1 , . . . , X50 ) = −0.6 + 0.25X1 + 0.25 ∗ X2 + 0.5(X1 ∗ X2 ),
F2 (X1 , . . . , X50 ) = −0.5 + 0.5(X1 ∗ X2 ),
F3 (X1 , . . . , X50 ) = −0.5 + 0.5((X1 ∗ X2 ) OR (X11 ∗ X12 )),
F4 (X1 , . . . , X50 ) = −0.5 + 0.5((X1 ∗ X2 ) OR (X1 ∗ X12 )),
where in function F3 and F4 , the OR operator returns value 1 if at least one of the two product
terms is 1. Among these four models, model 1 presents the standard logistic regression model
with two SNPs involved, model 2 assumes that only when there are two mutations on SNP1
and SNP2 from pathway 1 does the disease risk increase, model 3 assumes that there are two
independent pathways involved; and model 4 also assumes that there are two pathways involved
in disease risk; however, it assumes that SNP1 is involved in both pathways. For each model,
the estimated disease rate is about 30%. We simulate data sets of 500 individuals and for each
model, we repeat the simulation 100 times.
In the following analysis, we use the tree of depth three (i.e., at most three terminal nodes)
as the base leaner procedure, which allows for two-way interactions between the variables. Since
models 2-4 include only interaction effects, one would expect that the variable that entered in
the tree at the later stage has a higher improvement score than those entered before. In this
case, we adjust the important scores so that the two variables have the same importance scores.

4.1

Identification of the pathways

The four plots of Figure 1 show the frequencies during the pathway-based boosting procedure in
which each of the five pathways was selected. It is clear that for models 1 and 2, pathway 1 was
selected very frequently, and for models 3 and 4, both pathways 1 and 2 were selected almost
11
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equally, indicating the importance of these pathways to the risk of the disease. Similarly, the
four plots of Figure 2 show the boxplots of the relative importance scores of the five pathways
over 100 replications. We observed that the relative importance scores are higher for pathway 1
for models 1 and 2, and are higher for pathways 1 and 2 for models 3 and 4, indicating that the
pathway relative scores can indeed reveal which pathways are relevant to the disease risk.

4.2

Identification of the genes

To evaluate how well the proposed importance scores can be used for identifying genes that are
related to the risk of disease, Table 1 shows the percentage of the true SNPs appearing in the
top scoring variables over the 100 replications. For example, SNP1 and SNP2 are the SNPs with
the first or second highest scores in 81% and 82% of the simulations for model 1 and 74% and
75% of the simulations for model 2. Similarly, for model 3, the relative importance scores for
SNP1, SNP2, SNP11 and SNP12 are in general higher than the other SNPs. Among the 100
replications, the SNP1 and SNP2 are among the top four SNPs with the highest scores in 71%
and 71% of the simulations, and SNP11 and SNP12 appeared among the top 4 SNPs in 59% and
58% of the simulations respectively. The SNP1 appeared among the top 3 SNPs in 84% of the
replications for model 4. In addition, for model 4, SNP2 and SNP12 appeared among the top 3
SNPs with the highest scores in 69% and 60% of the replications, respectively. These numbers
indicate that the relative importance scores can indeed capture the importance of the variables
in the estimate of the function F (X).
Figure 3 shows the boxplots of the importance scores for each of the 50 variables over 100
replications, indicating that the scores for the true SNPs are much higher than the other variables
in most of the replications. We can clearly see that for model 1 and model 2, the relative
importance scores for SNP1 and SNP2 are in general much higher than the other SNPs. Similarly
for model 3, the importance scores for SNP1, SNP2, SNP11 and SNP12 are higher. For model
12
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4, the importance score for SNP 1 is almost always the highest over 100 replications, indicating
the importance of this SNP.

4.3

Comparison to other methods

As a comparison, we also performed analyses on the simulated data sets using the gradient descent
boosting procedure of Friedman and the popular support vector machine method for feature selection as implemented in the program package GIST (http://microarray.cpmc.columbia.edu/gist).
Neither of these two methods tried to utilize the pathway information. Table 1 shows the percentage over 100 simulations that the relevant SNPs were identified by these two methods. It
is clear that the NPR methods tend to select the relevant SNPs more frequently than these two
methods and the improvement is substantial for models 2, 3 and 4. For model 1, which is the
standard logistic regression model including both main effects and interaction, the SVM seemed
to select the SNP1 slightly better than the NPR method, but the difference is not significant.
In addition, we also observed that the relative importance scores for the relevant variables obtained from the Friedman’s procedure and the SVM are not as large as those obtained from the
NPR. This comparison demonstrated the advantage of the pathway-based boosting procedure
for the NPR models in selecting relevant variables, especially when the models do not follow the
standard logistic regression models.

5

Application to lymph-node negative primary breast cancer data set

Wang et al. (2005) reported large Affymetrix-based gene expression profiling for 286 patients
with lymph-node-negative primary breast cancer. These patients were treated between 1980-1995
with age at surgery ranging 26-86 and a median age at surgery of 52 yrs. No patient received
13
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any adjuvant therapy. During the follow-up period, 180 of these patients were relapse-free at 5
yrs, and 106 of them developed distant metastasis. Gene expression profiling using Affymetrix
HG-133A was performed on all these patients, including 17,819 transcripts that were present
in two or more samples. We merged the Affymetrix probe IDs with SuperArray cancer related
pathways/genes (www.superarray.com) and identified a subset of 245 genes in 33 cancer-related
sub-pathways (see Table 2 for the pathways and the number of genes in each pathway). In
addition, a set of 188 cancer-related genes is also included in our analysis. The numbers of genes
within the pathways range from 2 (e.g., cell-cell adhesion and notch signaling pathways) and 81
genes (e.g., regulation of cell cycle).
We first performed the analysis using the logistic regression model (2). Using 10-fold cross
validation on misclassification error rates, we chose the number of boosting steps to be 75,
which gives an optimal misclassification error rate of 0.29. The left plot of Figure 4 shows
the pathways with high relative scores and also high frequencies that were selected during the
boosting procedure. We found that the Wnt pathway, the pathways related to apoptosis and cell
cycle, and regulation of cell cycle are most likely related to the risk of distant metastasis.
Under the same 10-fold cross validation partitions, we performed analyses using several other
well-known classifiers, including Random Forest, Bagging, Neural Network, BayesNet, Naive
Bayes, Decision Stump, Ada Boosting M1, Logistic regression using the Weka software package
(http://www.cs.waikato.ac.nz/ml/weka/) and SVM using the program GIST. The misclassifications that result from various procedures are shown in Table 3. It is clear that the NPR outperforms almost all of the competitors. This indicates that the pathways and genes selected by the
NPR procedure may indeed be related to the risk of distant metastasis in lymph-node-negative
breast cancer patients.
As a comparison, we also performed the analysis using the Cox model (3) with time to cancer
relapse as the outcome. The right plot of Figure 4 shows the pathways with high importance
14
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scores and high frequencies of being selected during the boosting procedure. The pathways
identified are quite comparable to those identified using the logistic regression model.

6

Discussion

As the large body of biological information on various aspects of the biological systems and
pathways is available through databases or metadata, it is important to utilize the information
in modeling genomics data, especially in identifying genes and their interactions and pathways
that might be related to the phenotypes. In this paper, we have introduced a nonparametric
pathway-based regression model and proposed to extend the gradient boosting procedure of
Friedman (2001) to obtain fits of such models. In addition, we have defined relative importance
scores for genes within pathways and relative pathway importance scores in order to identify genes
and pathways that might be related to the phenotypes. We have demonstrated the applications
of such NPR models using both simulations and analysis of a breast cancer data set. Different
from the traditional regression analysis, the proposed methods naturally incorporate biological
pathways information. Different, also, from the commonly used gene set enrichment analysis, our
method considers multiple pathways simultaneously and can easily incorporate other covariates.
The ensemble methods have been proposed mainly for predictive purposes, however, as
demonstrated by Breiman (2001) and Friedman (2001) and also by our simulations, these methods can also be used for identifying variables that are relevant to the phenotypes. Although the
interpretation of the resulting model is not as easy as that obtained from the traditional logistic
regression or Cox regression, such models are more flexible and require fewer assumptions of the
genetic effects. Although the relative importance scores used in this paper seem to perform well
for identifying relevant variables, much future research needs to be done to rigorously investigate
the problem of defining variable importance in the setting of ensemble methods. For example,
important future research should assess the statistical significance of such importance scores,
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by using bootstrap or permutations. In addition, it is also important to develop methods for
identifying interactions among the variables based on the resulting ensemble of trees. Jiang and
Owen (2002) proposed to apply a quasi-regression idea (An and Owen, 2001) for identifying the
components based on the black-box functions. Similar quasi regression might be developed for
the NPR models to identify important genes and pathways.
Another important issue that deserves further investigation is the sensitivity of the proposed
methods to the misspecification of the pathways information and misspecification of the model.
The first type of misspecification is that the genes included in the pathways do not really belong
to the pathways. However, this should not create a big problem since these wrongly included
genes should not be selected by the proposed methods. Another type of miss-specification is that
the related genes are not included in the respected pathways. The third type of misspecification
is that the relevant pathways are not included in the model. However, it should be noted that
all types of regression analysis have such potential misspecification of the models. In defining
our NPR model, we assume that genes within a pathway can interact; however, the pathways
activities affect the phenotype in an additive model conditioning on the genes that the pathways
include.
In summary, we have proposed a regression framework for identifying pathways and genes
that are related to clinical phenotypes. The model and the pathway-based boosting procedure
can be extended to include pathway specific gene-environment interactions to allow the same
environmental risk factors to interact differently with different pathways. As more genes and
pathways are being identified, we expect to see more applications of the proposed methods and
its future extensions in analysis of genomic data.
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Table 1: Simulation results: percentage of the true variables that are among the genes with
highest top two scores (for model 1 and 2), top four scores (for model 3) and top three scores (for
model 4) over 100 replications. NPR: proposed pathway-based boosting procedure for the NPR
models; GDB: the gradient boosting procedure of Friedman; SVM: support vector machine.
Model 1

Model 2

Method

X1

X1

NPR

.81 .82

.74 .75

GDB

.66 .68

SVM

.90 .82

X2

X2

Model 3
X1

X2

Model 4

X11 X12

X1

X2

X12

.71 .71

.59

.58

.84 .69

.60

.41 .47

.52 .59

.42

.44

.76 .44

.39

.32 .42

.45 .45

.41

.38

.81 .26

.26
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Table 2: Pathways considered in breast cancer data analysis, including the numbers of genes in
each pathway and a description of the pathways. The last set includes 188 genes that do not
belong to a particular pathway.
Pathway ID # of Genes Description
1
18
Anti-apoptosis
2
4
VHLCaspase activation
3
3
DNA damage response
4
24
Factors involved in other aspect of apoptosis
5
8
Induction of apoptosis
6
10
Induction of apoptosis by signals
7
6
Regulation of apoptosis
8
3
Apoptosis others
9
13
Cell cycle arrest
10
4
Cell cycle checkpoint
11
29
Factors involved in other aspect of cell cycle
12
81
Regulation of cell cycle
13
6
Cell differentiation cell fate determination
14
63
Cell growth and/or maintenance
15
41
Cell proliferation
16
11
Growth factors
17
46
Regulation of cell proliferation differentiation growth and volume
18
10
Cell migration and motility
19
2
Cell-cell adhesion
20
6
Cell-matrix adhesion
21
10
Metalloendopeptidases (MMPs) and MMP inhibitors
22
13
Cell surface receptor linked signal transduction
23
9
Frizzled and frizzled-2 Signaling Pathways
24
17
G-protein coupled receptor protein signaling pathway
25
2
Insulin receptor signaling pathway
26
4
integrin-mediated signaling pathway
27
29
Intracellular signaling cascade
28
6
JAK-STAT cascade
29
2
Notch signaling pathway
30
3
RAS protein signal transduction
31
4
Rho protein signal transduction
32
13
Small GTPase mediated signal transduction
33
16
Wnt receptor signaling pathway
34
188
Other cancer-related genes
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Hosted by The Berkeley Electronic Press

Table 3: Comparision of the average misclassification error rates of the NPR method and nine
commonly used procedures based on 10-fold cross-validation for the breast cancer data set.
Classifiers

10-fold error rate

Random Forest

.33

Decision Stump

.42

Logistic Regression

.36

Neural Network

.29

Naive Bayes

.34

Bayes Net

.40

Bagging

.35

Ada Boost(M1)

.33

SVM

.42

NPR

.29
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Figure 1: Simulation results: frequencies of the pathways selected during the pathway-based
boosting procedure over 100 replications for each of the four simulated models.
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Figure 2: Simulation results: the boxplots of the relative importance scores for the four pathways
based on 100 replications for each of the four simulated models.
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Figure 3: Simulation results: the boxplots of the relative imporance scores from the NPR models
for each of the 50 variables over 100 replications.
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Figure 4: Results from analysis of breast cancer data set: plot of the frequencies of the pathways selected and the pathway importance scores during the boosting procedure for the logistic
regression model (left plot) and the Cox model (right plot).
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